Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.6K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.6K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

4.2K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
Bone Remodeling01:40

Bone Remodeling

41.0K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.0K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

8.3K
8.3K
Bone Disorders01:29

Bone Disorders

6.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shock-press: an Italian national survey investigating the use of vasopressors in cardiac patients experiencing cardio-circulatory shock.

Minerva anestesiologica·2026
Same author

Perioperative antithrombotic management in elective neurosurgery: a survey from the Lombardia Neurocritical Care Network, Italy.

Minerva anestesiologica·2026
Same author

Postoperative Respiratory Support After Cardiac Surgery: The BREASE ARC International Survey.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Hijacking client instability to selectively disrupt HSP90-driven glucocorticoid receptor activation.

Pharmacological research·2026
Same author

Long-term neurological outcomes after extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest: a 14-year single-centre cohort study.

Resuscitation·2026
Same author

The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization.

Cell death & disease·2026

Related Experiment Video

Updated: Mar 22, 2026

Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.1K

TSP-1 interaction with RANK and OPG: implications for bone remodeling and osteolytic bone metastasis.

Laura Carminati1, Fabio Sangalli2, Chiara Urbinati3

  • 1Laboratory of Tumor Microenvironment, Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Cell Death & Disease
|March 21, 2026
PubMed
Summary

A novel C-terminal fragment of thrombospondin-1 (TSP-1), E123CaG, inhibits osteoclast differentiation and bone breakdown in breast cancer metastasis. This fragment protects bone and prolongs survival by dual action on RANK signaling and osteoprotegerin (OPG).

More Related Videos

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

17.7K
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.9K

Related Experiment Videos

Last Updated: Mar 22, 2026

Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.1K
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

17.7K
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.9K

Area of Science:

  • Biochemistry
  • Oncology
  • Bone Biology

Background:

  • Osteolytic bone metastasis, particularly from breast cancer, causes significant morbidity and mortality.
  • Thrombospondin-1 (TSP-1) is a matricellular protein involved in tissue remodeling and cancer progression.
  • Understanding TSP-1's role in bone metastasis is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the role of TSP-1 in regulating bone remodeling during osteolytic bone metastasis.
  • To identify specific TSP-1 fragments involved in controlling osteoclast activity.
  • To explore the therapeutic potential of TSP-1 fragments in preventing bone destruction.

Main Methods:

  • Identification and characterization of a C-terminal TSP-1 fragment (E123CaG).
  • Assays to assess osteoclast differentiation and activity in vitro.
  • Analysis of downstream signaling pathways (MAPKs, NFATc1) and receptor interactions (RANK, OPG).
  • In vivo studies using a murine model of osteolytic bone metastasis.

Main Results:

  • The TSP-1 fragment E123CaG directly inhibited RANKL-induced osteoclast differentiation.
  • E123CaG impaired RANK signaling by blocking early and late downstream effectors.
  • E123CaG enhanced osteoprotegerin (OPG) activity by preventing its degradation.
  • In vivo, E123CaG expression reduced osteolytic lesions and improved survival in a breast cancer bone metastasis model.

Conclusions:

  • A C-terminal TSP-1 fragment (E123CaG) acts as a potent inhibitor of osteoclastogenesis and osteolysis.
  • E123CaG exhibits a dual mechanism of action: inhibiting RANK signaling and potentiating OPG.
  • This TSP-1 fragment demonstrates therapeutic potential for managing bone metastases and preventing bone loss.